According to Iovance Biotherapeutics
's latest financial reports the company has ยฃ0.61 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $ยฃ0.45 B | 11.11% |
2022-12-31 | $ยฃ0.41 B | -10.33% |
2021-12-31 | $ยฃ0.46 B | -4.38% |
2020-12-31 | $ยฃ0.48 B | 111.25% |
2019-12-31 | $ยฃ0.22 B | -37.92% |
2018-12-31 | $ยฃ0.36 B | 241.19% |
2017-12-31 | $ยฃ0.10 B | -20.43% |
2016-12-31 | $ยฃ0.13 B | 92.72% |
2015-12-31 | $ยฃ70.19 M | 143.7% |
2014-12-31 | $ยฃ28.8 M | 169.9% |
2013-12-31 | $ยฃ10.67 M | -252.39% |
2012-12-31 | $-ยฃ7.01 Million | -14.83% |
2011-12-31 | $-ยฃ8.23 Million | -2089.38% |
2010-12-31 | $ยฃ0.41 M | -5059.04% |
2009-12-31 | $-ยฃ0.01 Million | -634.86% |
2008-12-31 | $ยฃ0 M |